![Antegenes](https://storage.googleapis.com/dealroom-images-production/87/MTAwOjEwMDpjb21wYW55QHMzLWV1LXdlc3QtMS5hbWF6b25hd3MuY29tL2RlYWxyb29tLWltYWdlcy8yMDI0LzA3LzEwL2VlYmFjMGZkZDcwNGVhYWI0ZTcyMTdkMDIyMjQzNzEw.png)
Antegenes
VerifiedDigital health company implementing advanced genetic tests for personalized prevention of cancer and other complex diseases.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$7—11m (Dealroom.co estimates Aug 2022.)
Company register number 14489312
Tartu Tartu maakond (HQ)
USD | 2021 | 2022 | 2023 |
---|---|---|---|
Revenues | 0000 | 0000 | 0000 |
% growth | - | 179 % | 15 % |
EBITDA | 0000 | 0000 | 0000 |
Profit | 0000 | 0000 | 0000 |
EV / revenue | 00.0x | 00.0x | 00.0x |
EV / EBITDA | 00.0x | 00.0x | 00.0x |
R&D budget | 0000 | 0000 | 0000 |
Get premium to view all results
Date | Investors | Amount | Round |
---|---|---|---|
- | investor | $0.0 | round |
investor | $0.0 | round | |
N/A | $0.0 | round | |
investor investor investor investor | $0.0 | round | |
investor | $0.0 | round | |
investor | $0.0 | round | |
* | €50.0k | Grant | |
Total Funding | 000k |